Brumm Joshua T
Chief Executive Officer
Brumm Joshua T has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Brumm Joshua T is listed as Chief Executive Officer at CRESCENT BIOPHARMA, INC. Inside the rolling window, Brumm Joshua T reported no open-market purchases and 3 open-market sales totaling $921K in CBIO. The largest disclosed transaction in the window is a sale of 42,305 CBIO shares on Jun 22, 2026, worth $761K.
Companies traded
Other insiders at CBIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$921K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brumm Joshua T made?
Brumm Joshua T has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Brumm Joshua T trade?
Brumm Joshua T has filed SEC Form 4 disclosures for 1 company, including CBIO.
When was Brumm Joshua T's most recent SEC Form 4 filing?
Brumm Joshua T's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Brumm Joshua T's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brumm Joshua T is listed as Chief Executive Officer.
What is Brumm Joshua T's total buy and sell value in the current window?
Inside the rolling retention window, Brumm Joshua T bought $0 and sold $921K based on SEC Form 4 filings.
What was Brumm Joshua T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 42,305 CBIO shares on 2026-06-22, worth $761K, per SEC Form 4 filings.